Bought
Maintained
Sold
Other funds holding HCM
MGIM
GA
BG
CGIM
AG
Aviva's HCM Position: Q4 2022 in Review
Aviva sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 47,600 shares — an estimated $422K sold.
Aviva first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $1.42M in Q4 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.
- Aviva reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
- Aviva sold 47,600 HUTCHMED shares in Q4 2022, an estimated $422K.
- Aviva first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
- Aviva's HUTCHMED position peaked at $1.42M in Q4 2021.
- 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.
Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.